Clinical Trials

Study Title:
A Phase 1b Dose Escalation Study Of Metabolically Fit Cd19 Chimeric Antigen Receptor (Car) T Cells With Cd34 Selection Markers In Adult Patients With Relapsed Or Refractory Cd19 B Cell Non Hodgkin Lymphoma And Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

For more information about the trial above please contact the study team: Medical University of South Carolina Principal Investigator, Brian Hess, at hessbr@musc.edu. Study Coordinator, Sarah Milligan, at millisar@musc.edu. Trial opened at the following institutions: Medical University of South Carolina